IntelGenx Technologies Corp (IGXT)

[specular]

The issue on the Migraine is that they did submit a fully tested product to the FDA - the problem is the FDA challenged them on the reliability of the supplier for the 'active' component of the product. Now Zerbe has to rerun all the stabilities over again, but with active from a different supplier.

That mistake of not either fully qualifying the supplier, or having two independent suppliers (which is typical) was pure amateur hour by Zerbe.

And you don't wait for the approval to negotiate a better deal. You either have a product to sell or you don't. You strike a deal on the assumption it will have approval - if you don't get approval then it's all a mute point.

Bottom line is once Zerbe takes off his lab coat - he's worse than useless, he's counterproductive. Man hasn't got a business bone in his whole body.

What's the 50 buck blog you mention - don't know about that one.